Feds look to speed up full approval of Pfizer vaccine

The FDA is ramping up its timeline to fully approve Pfizer-BioNTech’s two-shot COVID-19 vaccine, amid the surge of infections gripping much of the US.

Health officials have an unofficial deadline of Labor Day or sooner to fully approve the manufacturers’ vaccine, which is now one of three approved on an emergency basis in the US, according to The New York Times. That accelerated timetable would require an “all-hands-on-deck approach” to green light the vaccine several weeks before President Biden’s stated goal of early fall, the report said.